top of page

Retatrutide is a next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. It is studied for its potential to produce synergistic metabolic effects by combining three distinct hormonal pathways — reducing appetite, improving insulin sensitivity, and increasing energy expenditure — making it a subject of significant interest in preclinical obesity and metabolic research.

Retatrutide

From $125.00Sale Price
Quantity
bottom of page